Published in Proc Natl Acad Sci U S A on April 01, 1988
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet (2012) 15.21
CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res (1990) 3.46
Measurement of the binding of transcription factor Sp1 to a single GC box recognition sequence. Nucleic Acids Res (1989) 2.47
DNA methylation. The effect of minor bases on DNA-protein interactions. Biochem J (1990) 2.09
Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet (1999) 1.93
Inactive chromatin spreads from a focus of methylation. Mol Cell Biol (1993) 1.83
DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma. Blood (2010) 1.77
The gut-enriched Krüppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J Biol Chem (1998) 1.76
Epigenetics of reprogramming to induced pluripotency. Cell (2013) 1.73
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol (2003) 1.72
Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest (1997) 1.63
Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol (2004) 1.62
Functional interference of Sp1 and NF-kappaB through the same DNA binding site. Mol Cell Biol (1998) 1.60
DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation. Mol Cell Biol (2002) 1.57
The DNA methylome. FEBS Lett (2010) 1.38
Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Sp1. Proc Natl Acad Sci U S A (1992) 1.35
Cytosine methylation in CTF and Sp1 recognition sites of an HSV tk promoter: effects on transcription in vivo and on factor binding in vitro. Nucleic Acids Res (1989) 1.35
Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol Cell Biol (1994) 1.33
Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol Cell Biol (2003) 1.33
All and only CpG containing sequences are enriched in promoters abundantly bound by RNA polymerase II in multiple tissues. BMC Genomics (2008) 1.28
Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem (2013) 1.24
Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo. EMBO J (1991) 1.23
Identification and characterization of the human XIST gene promoter: implications for models of X chromosome inactivation. Nucleic Acids Res (1997) 1.20
Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent. Mol Cell Biol (2000) 1.14
MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. Hepatology (2013) 1.09
High-resolution methylation analysis of the human hypoxanthine phosphoribosyltransferase gene 5' region on the active and inactive X chromosomes: correlation with binding sites for transcription factors. Mol Cell Biol (1994) 1.07
Adenovirus type 2 VAI RNA transcription by polymerase III is blocked by sequence-specific methylation. J Virol (1991) 1.06
Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression. Mol Cell Biol (1993) 1.04
Characterization of the human 5-lipoxygenase gene promoter. Proc Natl Acad Sci U S A (1990) 1.03
Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children's health research. FASEB J (2014) 1.02
The functional domains of the murine Thy-1 gene promoter. Mol Cell Biol (1991) 0.99
DNA methylation represses the murine alpha 1(I) collagen promoter by an indirect mechanism. Mol Cell Biol (1994) 0.99
Gene structure and transcription in mouse cells with extensively demethylated DNA. Mol Cell Biol (1989) 0.98
The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat. Am J Hum Genet (1998) 0.97
Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J (1994) 0.97
Binding of the transcription factor EBP-80 mediates the methylation response of an intracisternal A-particle long terminal repeat promoter. Mol Cell Biol (1991) 0.97
Lack of correlation between DNA methylation and transcriptional inactivation: the chicken lysozyme gene. Proc Natl Acad Sci U S A (1991) 0.96
DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11. Epigenetics (2013) 0.96
DNA methylation patterns associated with asparagine synthetase expression in asparagine-overproducing and -auxotrophic cells. Mol Cell Biol (1989) 0.95
Characterization of FMR1 promoter elements by in vivo-footprinting analysis. Am J Hum Genet (1997) 0.95
Multiple in vivo footprints are specific to the active allele of the X-linked human hypoxanthine phosphoribosyltransferase gene 5' region: implications for X chromosome inactivation. Mol Cell Biol (1992) 0.95
Hemimethylation of DNA prevents chromatin expression. Proc Natl Acad Sci U S A (1990) 0.95
5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression. Mol Cell Biol (1992) 0.94
Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma. J Mol Diagn (2005) 0.92
DNA methylation and differentiation. Environ Health Perspect (1989) 0.91
Low pH enhances Sp1 DNA binding activity and interaction with TBP. Nucleic Acids Res (2003) 0.89
A promoter-linked coupling region required for stimulation of alpha-fetoprotein transcription by distant enhancers. Nucleic Acids Res (1993) 0.87
DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours. Br J Cancer (1999) 0.86
Epigenetic regulation of glucose transporter 4 by estrogen receptor β. Mol Endocrinol (2011) 0.86
On the epigenetics of vascular regulation and disease. Clin Epigenetics (2012) 0.85
The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter. Biochem J (2005) 0.83
Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter. J Med Genet (2002) 0.82
Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer. Genes Chromosomes Cancer (2009) 0.81
A nuclear protein with enhanced binding to methylated Sp1 sites in the AIDS virus promoter. Nucleic Acids Res (1993) 0.79
Specificity proteins Sp1 and Sp3 interact with the rat GTP cyclohydrolase I proximal promoter to regulate transcription. J Neurochem (2007) 0.77
Gene regulation in the vascular endothelium: why epigenetics is important for the kidney. Semin Nephrol (2012) 0.77
Hypermethylated LTR retrotransposon exhibits enhancer activity. Epigenetics (2017) 0.75
DNA methylation within the I.4 promoter region correlates with CYPl19A1 gene expression in human ex vivo mature omental and subcutaneous adipocytes. BMC Med Genet (2013) 0.75
The role of DNA methylation in regulation of the murine Lhx3 gene. Gene (2013) 0.75
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61
The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell (1983) 15.09
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (1987) 14.62
Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science (1986) 12.58
Eukaryotic gene transcription with purified components. Methods Enzymol (1983) 9.71
Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell (1983) 8.85
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science (1986) 8.01
Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell (1987) 7.75
Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature (1984) 7.57
Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell (1987) 7.51
Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression. Mol Cell Biol (1986) 7.06
Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature (1985) 6.77
Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature (1987) 6.76
DNA methylation and the regulation of globin gene expression. Cell (1983) 6.49
Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc Natl Acad Sci U S A (1987) 4.68
DNA methylation affects the formation of active chromatin. Cell (1986) 4.65
Promoter region of the human Harvey ras proto-oncogene: similarity to the EGF receptor proto-oncogene promoter. Science (1985) 3.59
Structural and functional analysis of the human metallothionein-IA gene: differential induction by metal ions and glucocorticoids. Cell (1984) 3.08
Clonal inheritance of the pattern of DNA methylation in mouse cells. Proc Natl Acad Sci U S A (1982) 2.52
A sensitive and rapid gel retention assay for nuclear factor I and other DNA-binding proteins in crude nuclear extracts. Nucleic Acids Res (1986) 2.45
Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A (1987) 2.35
Binding of the Sp1 transcription factor by the human Harvey ras1 proto-oncogene promoter. Science (1986) 2.08
Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc Natl Acad Sci U S A (1982) 1.84
Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. Dev Biol (1978) 1.76
Metal-responsive elements act as positive modulators of human metallothionein-IIA enhancer activity. Mol Cell Biol (1987) 1.62
A protein from human placental nuclei binds preferentially to 5-methylcytosine-rich DNA. Nature (1984) 1.61
Ultraviolet radiation-induced metallothionein-I gene activation is associated with extensive DNA demethylation. Cell (1983) 1.47
Complete DNA methylation does not prevent polyoma and simian virus 40 virus early gene expression. Proc Natl Acad Sci U S A (1983) 1.39
Effect of 5-azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60). Cancer Res (1983) 1.38
Structure and tissue-specific expression of the human metallothionein IB gene. Mol Cell Biol (1986) 1.35
5-Azacytidine is able to induce the conversion of teratocarcinoma-derived mesenchymal cells into epithelia cells. EMBO J (1984) 1.05
Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants. Cancer Res (1983) 1.05
Induction of prolactin-deficient variants of GH3 rat pituitary tumor cells by ethyl methanesulfonate: reversion by 5-azacytidine, a DNA methylation inhibitor. Proc Natl Acad Sci U S A (1982) 1.05
Factor interactions at simian virus 40 GC-box promoter elements in intact nuclei. Mol Cell Biol (1987) 0.98
The effects of 5-azacytidine on the expression of the rat growth hormone gene. Methylation modulates but does not control growth hormone gene activity. J Biol Chem (1984) 0.89
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61
Mammalian MAP kinase signalling cascades. Nature (2001) 18.89
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell (1994) 16.30
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med (1997) 14.51
A method for isolation of intact, translationally active ribonucleic acid. DNA (1983) 13.67
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta (1991) 11.78
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56
A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature (1997) 11.31
Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (1995) 11.16
Cellular differentiation, cytidine analogs and DNA methylation. Cell (1980) 10.15
Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev (1993) 10.01
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell (1996) 9.68
Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell (1995) 9.30
The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell (1997) 8.74
The regulation of transcription by phosphorylation. Cell (1992) 7.99
AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell (2001) 7.79
The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell (1988) 7.76
Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell (1987) 7.75
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66
Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature (1984) 7.57
Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature (1988) 7.45
Human metallothionein genes--primary structure of the metallothionein-II gene and a related processed gene. Nature (1982) 7.05
Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell (1991) 6.89
Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell (1990) 6.84
Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature (1987) 6.76
The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell (1988) 6.75
Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol (2001) 6.73
Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell (1979) 6.47
IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature (1998) 6.15
Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (1994) 6.07
AP-1 in cell proliferation and survival. Oncogene (2001) 6.07
Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science (1999) 5.95
The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med (1999) 5.79
Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature (1994) 5.65
Multiple Ras functions can contribute to mammalian cell transformation. Cell (1995) 5.24
Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science (1999) 5.15
Inhibition of JNK activation through NF-kappaB target genes. Nature (2001) 5.03
Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells. J Biol Chem (1981) 4.86
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science (1990) 4.80
p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (1994) 4.77
The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res (1999) 4.74
Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature (1991) 4.74
Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science (1995) 4.74
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (2000) 4.66
Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res (1997) 4.65
Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol (1996) 4.56
JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev (1994) 4.50
Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature (1989) 4.42
JNK is involved in signal integration during costimulation of T lymphocytes. Cell (1994) 4.36
Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med (1994) 4.34
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res (1995) 4.28
Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell (1989) 4.17
Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature (1991) 4.17
The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell (1992) 4.04
Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res (1986) 3.95
Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature (1987) 3.94
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene (2006) 3.89
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE (1999) 3.79
Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol Cell Biol (1997) 3.77
Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol (1991) 3.70
Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene. EMBO J (1987) 3.65
p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. Genes Dev (1993) 3.64
The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell (1988) 3.64
Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science (1996) 3.56
c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell (1996) 3.54
Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev (1999) 3.51
Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell (1994) 3.44
Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev (1999) 3.41
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature (1996) 3.37
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem (1999) 3.34
Primary structure and transcription of an amplified genetic locus: the CUP1 locus of yeast. Proc Natl Acad Sci U S A (1984) 3.28
5-methylcytosine, gene regulation, and cancer. Adv Cancer Res (1983) 3.27
Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science (1998) 3.26
NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science (1993) 3.25
Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J (1995) 3.19
A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev (1988) 3.13
IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell (2001) 3.10
Structural and functional analysis of the human metallothionein-IA gene: differential induction by metal ions and glucocorticoids. Cell (1984) 3.08
Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J (1989) 3.01
Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell (1992) 2.99
p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol (2000) 2.96
Metallothioneins: proteins in search of function. Cell (1985) 2.95
Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol (1996) 2.89
Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol (1995) 2.89
Is NF-kappaB the sensor of oxidative stress? FASEB J (1999) 2.86
Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res (1998) 2.83
Predicting survival using simple clinical variables: a case study in traumatic brain injury. J Neurol Neurosurg Psychiatry (1999) 2.83
Altering gene expression with 5-azacytidine. Cell (1985) 2.79
Activation of a heterologous promoter in response to dexamethasone and cadmium by metallothionein gene 5'-flanking DNA. Cell (1984) 2.78
JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74
Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell (2000) 2.74
Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol (1990) 2.73
Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta (1997) 2.72
Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell (2000) 2.70
DNA methylation decreases in aging but not in immortal cells. Science (1983) 2.67